APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
Apollomics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$22.05+0.95 (+4.49%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$14.60 (−39.84%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Apollomics Inc. reported revenue of $8.50M for fiscal 2025.
Revenue
$8.50M
FY2025
EPS, diluted
-$7.57
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $8.50M
- EPS, diluted
- -$7.57
Seven years at a glance
Fiscal years 2019 to 2025, USD
Revenue
$8.50M
Operating income
–
EPS, diluted
-$7.57
Free cash flow
–
Reported period